Associations of baseline blood pressure levels and efficacy of benazepril treatment with interaction of α-adducin and ACE gene polymorphisms in hypertensives

Clinical and Experimental Hypertension

Volumn 27, Issue 1, 2005, Pages 83-94

  Yu, Yunxian ^a   Niu, Tianhua ^b   Venners, Scott Alan ^b   Zhang, Yan ^b   Chen, Changzhong ^b   Huang, Aiqun ^a   Feng, Yan ^b   Li, Dong ^a   Xing, Houxun ^c   Wu, Di ^c   Peng, Shaojie ^c   Xu, Xiping ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

adducin; Angiotensin I converting enzyme; Benazepril; Essential hypertension; Genetics; Polymorphism

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ACE GENE; ADULT; ALPHA ADDUCIN GENE; ARTICLE; BASELINE BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHINESE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; BENZAZEPINES; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 20044378315     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200044273     Document Type: Article

References (37)

1. Niu T, Xu X, Rogus J, Zhou Y, Chen C, Yang J, Fang Z, Schmitz C, Zhao J, Rao VS, Lindpaintner K. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101(1):188-194.
2. Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 2002; 62(7):977-993.
3. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990; 66:883-890.
4. Skeggs LT, Marsh WH, Khan JR, Shumway NP. The existence of two forms of hypertension. J Exp Med 1954; 99:275-282.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
6. Ruprecht B, Schurmann M, Ziegenhagen MW, vom Bauer E, Meier D, Schlaak M, Muller-Quernheim J. Corrected normal values for serum ACE by genotyping the deletion-/insertion-polymorphism of the ACE gene. Pneumologie 2001; 55(7):326-332.
7. Qu H, Lu Y, Lin S. Meta-analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population. Zhonghua Yu Fang Yi Xue Za Zhi 2001; 35(6):408-411.
8. Kaiser HW, O'Keefe E, Bennett V. Adducin. Ca11-dependent association with sites of cell-cell contact. J Cell Biol 1989; 109:557-569.
9. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio P-C, Bianchi G. Hypertension associated point mutations in the adducin a and b subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97:2815-2822.
10. Mische SM, Mooseker MS, Morrow JS. Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding. J Cell Biol 1987; 105:2837-2845.
11. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphism of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353-1357.
12. Barlassina C, Schork NJ, Manunta P, Citterio L, Sciarrone M, Lanella G, Bianchi G, Cusi D. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000; 57(3):1083-1090.
13. Clark CJ, Davies E, Anderson NH, Farmer R, Friel EC, Fraser R, Connell JM. α-Adducin and angiotensin I-converting enzyme polymorphisms in essential hypertension. Hypertension Dec. 2000; 36:990-994.
14. Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, Saga D, Kondo D, Akazawa K, Sakatsume M, Gejyo F. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 2003; 42(3):304-309.
15. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. ACE and α-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003; 41:398-403.
16. Balfour JA, Goa KL. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 1991; 42(3):511-539.
17. Weihua C, Liming L, Yonghua H, Shiyan Z, Xiaohui L, Fan L, Tao W, Jun L, Tao W. Evaluation of the effect of Benazapril for hypertension through postmarketing surveillance (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21(3):190-193.
18. Haziza HM, Francillon A, Mottier D, Heintzmann F, Serrurier D. Antihypertensive action and predictive factors of efficacy of Benazapril in mild-to-moderate hypertension: clinical trial in general medical practice on 16,987 patients. Ann Cardiol Angeiol (Paris) 1998; 47(1):33-41.
19. Buffone GJ, Darlington GJ. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem 1985; 31:164-165.
20. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
21. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Ferryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342:1073-1075.
22. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1085-1086.
23. Schunkert H, Hense H-V, Holmer SR. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
24. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, Perrotti N, Tramontano D, Mattioli PL. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 1997; 29:365-369.
25. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184(1):9-15.
26. Morshed M, Khan H, Akhteruzzaman S. Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J Biochem Mol Biol 2002; 35(3):251-254.
27. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992; 1:72-75.
28. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993; 191:399-404.
29. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart. Circulation 1998; 97:1766-1772.
30. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97:1773-1779.
31. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K. Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs. Hypertension 1999; 33(6):1332-1337.
32. Kato N, Sugiyama T, Nabika T, Morita H, Kurihara H, Yazaki Y, Yamori Y. Lack of association between the alpha-adducin locus and essential hypertension in the Japanese population. Hypertension 1998; 31(3):730-733.
33. Ishikawa K, Katsuya T, Sato N, Nakata Y, Takami S, Takiuchi S, Fu Y, Higaki J, Ogihara T. No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens 1998; 11(4 Pt 1):502-506.
34. Nicod J, Frey BM, Frey FJ, Ferrari P. Role of the α-adducin genotype on renal disease progression. Kidney Int 2002; 61:1270-1275.
35. Li X, Du Y, Du Y, Huang X. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol Ther 2003; 8(1):25-30.
36. Netea RT, Smits P, Lenders JW, Thien T. Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens 1998; 16(3):263-268.
37. He FJ, Markandu ND, MacGregor GA. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension 2001; 38:321-325.